These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17786364)

  • 1. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
    Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
    Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma.
    Yoshikawa K; Noguchi K; Nakano Y; Yamamura M; Takaoka K; Hashimoto-Tamaoki T; Kishimoto H
    Int J Oncol; 2015; 46(6):2364-70. PubMed ID: 25846049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
    Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
    Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin.
    Miyashita H; Nitta Y; Mori S; Kanzaki A; Nakayama K; Terada K; Sugiyama T; Kawamura H; Sato A; Morikawa H; Motegi K; Takebayashi Y
    Oral Oncol; 2003 Feb; 39(2):157-62. PubMed ID: 12509969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.
    Nakayama K; Miyazaki K; Kanzaki A; Fukumoto M; Takebayashi Y
    Oncol Rep; 2001; 8(6):1285-7. PubMed ID: 11605050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.
    Katano K; Kondo A; Safaei R; Holzer A; Samimi G; Mishima M; Kuo YM; Rochdi M; Howell SB
    Cancer Res; 2002 Nov; 62(22):6559-65. PubMed ID: 12438251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U
    BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.
    Matsumoto S; Tanaka T; Kurokawa H; Matsuno K; Hayashida Y; Takahashi T
    Anticancer Res; 2007; 27(4B):2209-16. PubMed ID: 17695505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
    Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
    Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
    Komatsu M; Sumizawa T; Mutoh M; Chen ZS; Terada K; Furukawa T; Yang XL; Gao H; Miura N; Sugiyama T; Akiyama S
    Cancer Res; 2000 Mar; 60(5):1312-6. PubMed ID: 10728692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin.
    Safaei R; Adams PL; Maktabi MH; Mathews RA; Howell SB
    J Inorg Biochem; 2012 May; 110():8-17. PubMed ID: 22459168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells.
    Doherty B; Lawlor D; Gillet JP; Gottesman M; O'Leary JJ; Stordal B
    Anticancer Res; 2014 Jan; 34(1):503-7. PubMed ID: 24403508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper transport systems are involved in multidrug resistance and drug transport.
    Furukawa T; Komatsu M; Ikeda R; Tsujikawa K; Akiyama S
    Curr Med Chem; 2008; 15(30):3268-78. PubMed ID: 19075668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression.
    Wang X; Zhu W; Zhao X; Wang P
    Int J Mol Med; 2016 Jun; 37(6):1636-42. PubMed ID: 27121102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin.
    Huang CP; Fofana M; Chan J; Chang CJ; Howell SB
    Metallomics; 2014 Mar; 6(3):654-61. PubMed ID: 24522273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinomas.
    Kanzaki A; Nakayama K; Miyashita H; Shirata S; Nitta Y; Oubu M; Higashimoto M; Mutoh M; Mori S; Konno S; Ogawa K; Toi M; Takebayashi Y
    Anticancer Res; 2003; 23(2C):1913-5. PubMed ID: 12820478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.